Pfizer (PFE) Akcija Cena
Pfizer Cena
Pēdējos 19 gados Pfizer ieņēmumi auga par 1,4 % gadā un sasniedza 62,58 B USD. Peļņa uz akciju samazinājās par 0,6 % gadā pēdējos 19 gados. Pfizer neto marža 12,4 % ir samazinājusies salīdzinājumā ar 27,2 % pirms dažiem gadiem. Pie šodienas cenas dividenžu ienesīgums ir aptuveni 5,59 %. Izmaksas koeficients ir ap 126 % no peļņas. Dividendes auga par 3,1 % gadā pēdējos 19 gados. Pfizer 12 mēnešu konsensa mērķa cena ir 27,00 USD, ap zem kursu par 12,3 %. No 34 analītiķiem 13 iesaka pirkt — kopējais konsenss ir Turēt.
Pfizer akcijas cena
Iegūstiet šos datus caur Eulerpool API
100 000 pieprasījumu/mēn. bez maksas · bez kartes
Pfizer biznesa modelis un akciju analīze
Bieži uzdotie jautājumi par Pfizer akciju
Pfizer Inc's business model is focused on pharmaceutical research, development, manufacturing, and sales. The company operates in various therapeutic areas, including but not limited to oncology, cardiovascular, immunology, and neurology. Pfizer's mission is to discover and develop innovative medicines that enhance the health and well-being of people worldwide. With a diverse portfolio of prescription medicines, vaccines, and consumer healthcare products, Pfizer strives to improve patient outcomes and provide effective healthcare solutions. Through strategic partnerships and collaborations, Pfizer continues to invest in research and development to address unmet medical needs and drive sustainable growth in the pharmaceutical industry.
Pfizer Inc is primarily active in the pharmaceutical industry.
The main competitors of Pfizer Inc in the market include pharmaceutical companies such as Johnson & Johnson, Novartis AG, Merck & Co., Inc., and GlaxoSmithKline plc.
Pfizer Inc. is a renowned pharmaceutical giant with a rich history and influential background. Established in 1849, Pfizer has evolved into one of the largest global pharmaceutical companies. Headquartered in New York City, Pfizer has played a pivotal role in the healthcare industry's advancement. The company is committed to developing innovative medicines and vaccines that improve and save lives worldwide. With its vast expertise, extensive research and development efforts, and strategic collaborations, Pfizer has introduced groundbreaking treatments for various diseases. As a leader in the pharmaceutical sector, Pfizer continues to prioritize delivering transformative healthcare solutions to address the evolving needs of patients and healthcare professionals.
Pfizer Inc has achieved significant milestones throughout its history. Founded in 1849, the company has become one of the world's leading pharmaceutical corporations. Notably, Pfizer developed and marketed groundbreaking drugs that have revolutionized medical treatments. In 1998, the company gained immense recognition with the introduction of Viagra, a medication for erectile dysfunction. Pfizer's research and innovation also led to the development of Lipitor, a cholesterol-lowering drug that became the best-selling prescription medicine worldwide. Furthermore, Pfizer remains dedicated to advancing healthcare by continuously expanding its product portfolio and pursuing collaborations to address unmet medical needs. With its rich history and commitment to innovation, Pfizer Inc continues to make significant contributions to the healthcare industry.
Pfizer Inc is primarily present in various countries and regions across the globe. The company has a widespread presence with operations in multiple key markets. Pfizer's global presence includes major countries such as the United States, United Kingdom, Germany, Japan, China, India, Brazil, and many more. With a diverse international footprint, Pfizer Inc continues to serve patients and healthcare professionals worldwide by delivering innovative healthcare solutions and medications.
Pfizer Inc, a renowned pharmaceutical company, represents values of integrity, excellence, and patient-centricity. With a strong corporate philosophy, Pfizer aims to improve the health and well-being of individuals worldwide through innovative medicines and therapies. Committed to scientific advancement, Pfizer provides quality healthcare solutions while upholding ethical practices. Through extensive research and development, they strive to discover and deliver life-saving and life-enhancing treatments. As a global leader in the healthcare industry, Pfizer's dedication to patient care, scientific ingenuity, and ethical principles are fundamental to their corporate philosophy and drive their mission to revolutionize healthcare for a better tomorrow.
Analītiķi pašlaik nosaka vidējo Pfizer akcijas mērķa cenu 27,38 USD (mediāna: 27,00 USD), kas ir -8,7 % pret pēdējo cenu. Konsenss balstās uz 34 analītiķu vērtējumiem.
34 analītiķi pašlaik vērtē Pfizer akciju: 13 iesaka pirkt, 18 turēt un 3 pārdot. 2026. gadam analītiķi sagaida, ka Pfizer gūs 62,24 B USD ieņēmumus un 2,97 USD peļņu uz akciju.
Pēc pašreizējā kursa Pfizer akcija maksā 27,40 EUR (30,79 USD).
Pfizer akcija (PFE) tiek kotēta 13 biržās, tostarp: NYSE (PFE), London (0Q1N.L), SIX (Zürich) (PFE.SW), XETRA (PFE.DE), Frankfurt (PFE.F), München (PFE.MU), Stuttgart (PFE.SG), Düsseldorf (PFE.DU).
Pfizer Inc is a multinational pharmaceutical company headquartered in New York City. The company operates in the research, development, production, and distribution of drugs. Pfizer is one of the largest pharmaceutical companies in the world. In this article, we will describe the business model of Pfizer Inc. Divisions Pfizer has divided its business operations into three main divisions: Biopharmaceuticals, Beyond the Baby Cure, and Contract Manufacturing. Biopharmaceuticals The Biopharmaceuticals division focuses on the research and development of drugs. The goal is to develop new drugs and therapies that meet the needs of patients. Research and development are focused on various areas such as oncology, cardiovascular, immunological, and neuroscience disorders. Pfizer has a strong pipeline with numerous drugs in late-stage clinical development. An example is the drug Tofacitinib, which is used to treat rheumatoid arthritis. In 2020, Pfizer generated revenue of $51.8 billion in this division. Beyond the Baby Cure The Beyond the Baby Cure division refers to products that are not drug-based. This includes products like vitamin-rich dietary supplements, pain relievers, condoms, and personal care products. Pfizer acquired Wyeth in 2006, a company active in this segment. This allowed Pfizer to expand its product portfolio. In 2020, Pfizer generated revenue of $2.5 billion in this segment. Contract Manufacturing Pfizer's Contract Manufacturing division refers to the production of drugs for other companies. The company offers services for the entire value chain, from drug manufacturing to logistics. In 2020, Pfizer generated revenue of $2.2 billion in this division. Products Pfizer offers a wide range of products covering various areas. Here are some of Pfizer's key products: - Viagra, a medication for the treatment of erectile dysfunction - Lyrica, a medication for the treatment of neuropathic pain - Prevnar, a vaccine for the prevention of pneumococcal infections - Xeljanz, a medication for the treatment of rheumatoid arthritis - Lipitor, a medication for lowering cholesterol levels Conclusion Pfizer is a leading pharmaceutical company with a broad portfolio of products and services. The company specializes in three main divisions: Biopharmaceuticals, Beyond the Baby Cure, and Contract Manufacturing. With a strong commitment to research and development and an impressive pipeline, Pfizer has a strong position in the industry.
gaidāmā apgrozījums Pfizer ir 62,24 B USD. Šis skaitlis ir balstīts uz pašreizējiem finanšu datiem un atspoguļo uzņēmuma biznesa sniegumu.
gaidāmā peļņa Pfizer ir 16,88 B USD. Neto peļņa atspoguļo uzņēmuma rentabilitāti pēc visu izdevumu atskaitīšanas.
Pfizer cenas un peļņas rādītājs (P/E) pašlaik ir 10,37. P/E rādītājs salīdzina pašreizējo akcijas cenu ar peļņu uz akciju un palīdz ieguldītājiem novērtēt Pfizer akcijas vērtību.
Pfizer cenas un apgrozījuma rādītājs (P/S) pašlaik ir 2,81. P/S rādītājs salīdzina tirgus kapitalizāciju ar gada apgrozījumu un kalpo kā Pfizer akcijas vērtības mērs.
Pfizer Eulerpool kvalitātes rādītājs ir 1/10.
Pfizer ISIN ir US7170811035. ISIN (International Securities Identification Number) ir pasaulē unikāls vērtspapīru identifikators.
Pfizer WKN ir 852009. WKN (Wertpapierkennnummer) ir sešciparu vācu vērtspapīru identifikācijas numurs.
Pfizer tikeris ir PFE. Tikeris tiek izmantots Pfizer akciju tirdzniecībai biržā.
Pfizer akcija
Pfizer Salīdzināmo uzņēmumu grupa
Pfizer Biržas kods
Pfizer FIGI
Visi Pfizer fundamentālie rādītāji un padziļinātā analīze
Mūsu akciju analīze par Pfizer ietver svarīgus finanšu rādītājus, piemēram, apgrozījumu, peļņu, P/E rādītāju, P/S rādītāju, EBIT, kā arī informāciju par dividendēm. Turklāt mēs aplūkojam aspektus kā akcijas, tirgus kapitalizāciju, parādus, pašu kapitālu un saistības no Pfizer. Ja meklējat sīkāku informāciju par šīm tēmām, piedāvājam detalizētas analīzes mūsu apakšlapās: